Agenus Investor Sues In Del. Chancery Over Option Awards
A shareholder of Agenus Inc. filed a derivative complaint on behalf of the biotech company in Delaware Chancery Court, arguing that Agenus board members and other executives breached their fiduciary duty...To view the full article, register now.
Already a subscriber? Click here to view full article